Seroprevalence of cytomegalovirus infection in the United States, 1988-1994 - Wikidata - awgldk - TriplyDB

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

http://www.wikidata.org/entity/Q28267544

about

Neglected infections of poverty in the United States of America Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention Loneliness predicts pain, depression, and fatigue: understanding the role of immune dysregulation Human cytomegalovirus and transplantation: drug development and regulatory issues CMV in Hematopoietic Stem Cell Transplantation Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease Progression T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines Meta-analysis of cytomegalovirus seroprevalence in volunteer blood donors and healthy subjects in Iran from 1992 to 2013 Cytomegalovirus infection in transplant recipients Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review Gender disparities in ocular inflammatory disorders The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications Viral inhibition of the transporter associated with antigen processing (TAP): a striking example of functional convergent evolution Herpesvirus reactivation and socioeconomic position: a community-based study An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities Pathogen Inactivating Properties and Increased Sensitivity in Molecular Diagnostics by PAXgene, a Novel Non-Crosslinking Tissue Fixative Identification and Function of MicroRNAs Encoded by Herpesviruses Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci Prevalence and risk factors for betaherpesvirus DNAemia in children >3 weeks and <2 years of age admitted to a large referral hospital in sub-Saharan Africa.Antiviral drug resistance of human cytomegalovirus.Epigenetic and immune function profiles associated with posttraumatic stress disorder.Viral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughput sequencing data.Antibody levels to persistent pathogens and incident stroke in Mexican Americans Incidence of cytomegalovirus infection among the general population and pregnant women in the United States.Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review.Cytomegalovirus infections among African-Americans.Importance of diagnostic work-up of Guillain-Barré syndrome in pregnancy.The use of artificial neural networks in prediction of congenital CMV outcome from sequence data.Prevalence of CMV infection among sexually active adolescents: a matched case-control study.Immunosenescence in the nursing home elderly.Neurologic presentations of AIDS.Incidence and risk factors for cytomegalovirus in kidney transplant patients in Babol, northern Iran.Association between cytomegalovirus antibody levels and cognitive functioning in non-elderly adults.Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study

P2860

Q21144547-685EAB41-34E4-478C-AE7C-2D066369721A Q21972778-6F561089-058E-4182-BF58-E2685DD1F2CC Q24235578-63573AFB-1C83-4DA5-ABCE-4558EF8E2DDD Q24293059-D30DD6AC-203A-4BF7-BFB4-4AE712950AFE Q24570124-84D57548-6AD4-49F9-A5FB-BDED67A36D38 Q24631784-D29A6FB9-50B8-4AE2-A204-D6B1FE497142 Q26700020-328075BC-689D-45F3-8132-9B0038321FEF Q26740385-B8226E32-838D-4E32-A7A0-7115461684F5 Q26751304-8183A021-D311-409B-9877-AF975474F119 Q26768539-3D99509C-E2F8-4D48-89B6-E72A5649188F Q26782428-7E92CA41-EE11-4EDD-AE72-6A7BA9F9ED41 Q26801802-5D166F27-602C-4A9B-AA0E-3A2F5997B34C Q26858774-DC8D6191-8477-4151-9E01-3B1889AC0DE3 Q26995402-B2304972-3AED-45FF-BB0F-C5E141610D30 Q27025076-D4B651DE-10FF-47C0-8BB8-0631B5B4EF5A Q28073770-86287955-8964-4816-AA26-0E209034E9BE Q28079823-D3EB7F6B-531B-434A-9B46-A7B586575C66 Q28083232-39D4C42C-F54B-4C30-9F63-B9CA1623DF4B Q28385076-5E157968-0BE4-45C8-B9FF-A8F82BA82B2E Q28476748-7152496B-479C-4C3D-8CC8-5D6113A762A4 Q28550737-5E19812C-7FC0-45F5-9690-A4376C48AE72 Q28749288-B54CDA03-C01C-4E2F-A8EC-AEC60C2D6A2C Q29417060-C941F55F-EC29-490F-AE86-E871E5AEE0CD Q30368207-3E636D6C-2A3F-49FF-8842-A7EC3CBE8FD0 Q30430427-20791D4E-B3FD-4C48-B240-A0F0D78EC46D Q30478641-CB8EB12E-2A11-4596-893B-FED85574DDDE Q30702069-A128278C-F16A-4B59-967D-90EA1DA038F2 Q31120630-44EB45F6-215E-4A02-A15C-7B0949C9C9BD Q33289670-2DE9197C-E7B7-4153-A173-57FD8F572FAD Q33326042-3AD46E56-B8BF-446A-8B2D-D9F69DDABC09 Q33357067-4362324B-D029-479C-98D1-58AB59E602F3 Q33437291-6E6A3397-5911-42B1-8326-F84BCB1F4EB2 Q33509301-50F82D74-C32A-41CF-AB56-7A2A7DC04FA9 Q33568496-F1E204AA-3E86-4CC5-92C4-74FA02D1841F Q33581463-DFD81AAD-D58F-4377-B7C9-54DA56E4CA49 Q33590337-C0013E89-46FF-45CA-B128-FD4CB1B24B8C Q33624126-57F73AC5-8A5C-47F0-8952-AC4177DA3F2D Q33638079-C8CF26E6-49B5-4CC5-B51E-248354C5EA90 Q33695591-B7E5F0F7-E26A-4F62-B00B-24D7A135B543 Q33811238-A9BAC8E6-71E7-422B-87DD-FB9BF77BBD68

P2860

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

http://www.wikidata.org/entity/Q28267544

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

@ast

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

@en

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

@nl

type

label

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

@ast

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

@en

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

@nl

prefLabel

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

@ast

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

@en

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

@nl

P1433

Q28267544-CAF0F122-EF5F-4FD6-A639-6BA074D25073

P1476

Q28267544-DDF453C9-9EB9-40BC-A068-7B281F92834D

P2093

Q28267544-1A7FAD6E-C6E4-42E1-AFCC-D12FFFFDF25A

Q28267544-2B461643-1A55-4E38-AB04-1B84CD48551E

Q28267544-5D9EBD58-5A1E-4AA4-87EA-A5618FBF2252

Q28267544-8CC5C843-D21A-40D2-ACBC-288DFCFC0928

Q28267544-98EF1B27-12CA-4BC9-BB80-B35B3077A3B4

P2860

Q28267544-0669D65F-5D4E-4DC1-9FE0-B89926A896A1

Q28267544-1CF4FB20-1734-4050-87D5-6971BF5B6304

Q28267544-2881ED63-6CB8-45A9-80E5-50224FCA5BA2

Q28267544-5FCCFB5D-23ED-4A88-90C0-E148A1F064C4

Q28267544-733C90FB-C1DD-49F8-B62C-221A04F8E55C

Q28267544-781AFD74-30B6-44D2-B21C-C922F01B57D4

Q28267544-7AB79086-7FB1-4392-AEB0-DFA5FA1DAF8F

Q28267544-7CD9B2A6-4DA5-4A3B-9AC5-7634B776A7D7

Q28267544-941FD724-8133-4FB1-87E3-1B34DBFDAACB

Q28267544-94A3C86D-51DF-4BEF-A45D-91871C1EF8AD

P304

Q28267544-A2E63F08-D919-4884-85E7-4994E9574528

P31

Q28267544-37D0F068-06E5-45C5-A021-FCAE620C39ED

P3181

Q28267544-A246757F-147F-4C39-A622-D0A4773D474F

P356

Q28267544-0BF71612-4727-4CA6-BC7B-29848C5B9E15

P407

Q28267544-CF565BD4-EB3D-4395-865B-92585CAB21F6

P433

Q28267544-5F808828-E20A-4CF0-8862-4E5F45EFB131

P478

Q28267544-96F6238C-1C79-48A2-8D76-DF7070C64BB3

P50

Q28267544-C3839B81-7EB5-4B51-B7E0-EA5839FA1C0B

P577

Q28267544-16AC31AE-CDE8-436A-B47E-555E01F6D172

P5875

Q28267544-C9081071-6B74-40A9-8EDC-DA6017FAE174

P698

Q28267544-1E3A2446-D805-49E2-8803-061DABEF2A44

P921

Q28267544-270976A6-FF60-42D2-A502-23F649929F5B

Q28267544-2C32FDE4-80EC-421B-A3D0-7BF0E0A20C9E

Q28267544-C7E18D3D-B6A1-43FE-B6AA-AF859A02B943

P3181

P356

P1433

Clinical Infectious Diseases

P1476

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

@en

P2093

Kay W Radford

http://www.w3.org/2001/XMLSchema#string

Robert F Pass

http://www.w3.org/2001/XMLSchema#string

Sheila C Dollard

http://www.w3.org/2001/XMLSchema#string

Stephanie A S Staras

http://www.w3.org/2001/XMLSchema#string

W Dana Flanders

http://www.w3.org/2001/XMLSchema#string

P2860

Washing our hands of the congenital cytomegalovirus disease epidemic.

Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis.

Congenital cytomegalovirus infection: review of the epidemiology and outcome.

Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection.

Cytomegalovirus prevalence in pregnant women: the influence of parity.

Early acquisition of cytomegalovirus infection.

Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1-seronegative and -seropositive women from an urban minority community.

Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus.

Prevalence of antibodies to human cytomegalovirus in urban, kibbutz, and Bedouin children in southern Israel.

Maternal immunity and prevention of congenital cytomegalovirus infection.

P304

1143-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

665800

http://www.w3.org/2001/XMLSchema#string

P356

10.1086/508173

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6766222

http://www.w3.org/2001/XMLSchema#string

P698

17029132

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

Cytomegalovirus